Tag: clinical

Science

Biopsied lacrimal glands in Japanese cohort: clinical

Chucky.

Biopsied lacrimal glands in Japanese cohort: clinical illustration

The important part of this research is not the drama of a single result, but what the result may let scientists do next. The immediate finding may be technical, but the long-term value is in what it could make safer, smarter, cheaper, faster, or easier to understand.

The test is not whether the discovery sounds impressive on first reading. It is whether the evidence is strong, the limits are clear, and the work gives other researchers a firmer platform for the next step.

Continue reading “Biopsied lacrimal glands in Japanese cohort: clinical” →

Science

Clinical pathways matter for multimodal deep learning in early Alzheimer’s disease detection

Chucky.

Clinical pathways matter for multimodal deep learning in early Alzheimer’s disease detection illustration

The important part of this research is not the drama of a single result, but what the result may let scientists do next. The immediate finding may be technical, but the long-term value is in what it could make safer, smarter, cheaper, faster, or easier to understand.

The test is not whether the discovery sounds impressive on first reading. It is whether the evidence is strong, the limits are clear, and the work gives other researchers a firmer platform for the next step.

Continue reading “Clinical pathways matter for multimodal deep learning in early Alzheimer’s disease detection” →

Science

Clinical responses to trastuzumab deruxtecan in molecularly defined ependymoma

Chucky.

Clinical responses to trastuzumab deruxtecan in molecularly defined ependymoma illustration

The important part of this research is not the drama of a single result, but what the result may let scientists do next. The immediate finding may be technical, but the long-term value is in what it could make safer, smarter, cheaper, faster, or easier to understand.

The test is not whether the discovery sounds impressive on first reading. It is whether the evidence is strong, the limits are clear, and the work gives other researchers a firmer platform for the next step.

Continue reading “Clinical responses to trastuzumab deruxtecan in molecularly defined ependymoma” →

Science

Recent advances in individual differences in addiction neuroscience in animal models

Chucky.

Recent advances in individual differences in addiction neuroscience in animal models illustration

The important part of this research is not the drama of a single result, but what the result may let scientists do next. The immediate finding may be technical, but the long-term value is in what it could make safer, smarter, cheaper, faster, or easier to understand.

The test is not whether the discovery sounds impressive on first reading. It is whether the evidence is strong, the limits are clear, and the work gives other researchers a firmer platform for the next step.

Continue reading “Recent advances in individual differences in addiction neuroscience in animal models” →

Science

Is emotion regulation a mechanism of change in virtual reality-assisted therapy

Chucky.

Is emotion regulation a mechanism of change in virtual reality-assisted therapy illustration

The important part of this research is not the drama of a single result, but what the result may let scientists do next. The immediate finding may be technical, but the long-term value is in what it could make safer, smarter, cheaper, faster, or easier to understand.

The test is not whether the discovery sounds impressive on first reading. It is whether the evidence is strong, the limits are clear, and the work gives other researchers a firmer platform for the next step.

Continue reading “Is emotion regulation a mechanism of change in virtual reality-assisted therapy” →

Science

GLP-1 receptor agonists and clinical outcomes in adults with Crohn’s disease

Chucky.

GLP-1 receptor agonists and clinical outcomes in adults with Crohn’s disease illustration

The important part of this research is not the drama of a single result, but what the result may let scientists do next. The immediate finding may be technical, but the long-term value is in what it could make safer, smarter, cheaper, faster, or easier to understand.

The test is not whether the discovery sounds impressive on first reading. It is whether the evidence is strong, the limits are clear, and the work gives other researchers a firmer platform for the next step.

Continue reading “GLP-1 receptor agonists and clinical outcomes in adults with Crohn’s disease” →

Science

Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk

Chucky.

Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk illustration

The important part of this research is not the drama of a single result, but what the result may let scientists do next. The immediate finding may be technical, but the long-term value is in what it could make safer, smarter, cheaper, faster, or easier to understand.

The test is not whether the discovery sounds impressive on first reading. It is whether the evidence is strong, the limits are clear, and the work gives other researchers a firmer platform for the next step.

Continue reading “Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk” →